Balyasny Asset Management’s Bioventus BVS Stock Holding History

Balyasny Asset Management’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,797	Closed	-$254K	–	3034
2026 Q1	$254K	Buy	27,797 +9,130	+49%	+$76.6K	﹤0.01%	2620
2025 Q4	$139K	Buy	+18,667	New	+$134K	﹤0.01%	2931
2025 Q2	–	Sell	-31,415	Closed	-$287K	–	2858
2025 Q1	$287K	Buy	31,415 +18,764	+148%	+$187K	﹤0.01%	2465
2024 Q4	$133K	Buy	+12,651	New	+$150K	﹤0.01%	2583
2024 Q2	–	Sell	-53,696	Closed	-$279K	–	2609
2024 Q1	$279K	Sell	53,696 -33,212	-38%	-$162K	﹤0.01%	2288
2023 Q4	$458K	Buy	+86,908	New	+$344K	﹤0.01%	1988
2023 Q3	–	Sell	-406,918	Closed	-$1.18M	–	2282
2023 Q2	$1.18M	Buy	+406,918	New	+$781K	﹤0.01%	1559
2021 Q4	–	Sell	-12,909	Closed	-$183K	–	2261
2021 Q3	$183K	Buy	+12,909	New	+$199K	﹤0.01%	1654

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Balyasny Asset Management's BVS Position: Q2 2026 in Review

Balyasny Asset Management sold out of Bioventus (BVS) in Q2 2026, closing a stake of 27,797 shares — an estimated $254K sold.

Balyasny Asset Management first reported a position in BVS in Q3 2021 and held it in 8 quarters. The position peaked at $1.18M in Q2 2023. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

Balyasny Asset Management reported no remaining Bioventus position as of Q2 2026 after selling out during the quarter.
Balyasny Asset Management sold 27,797 Bioventus shares in Q2 2026, an estimated $254K.
Balyasny Asset Management first reported a position in Bioventus in Q3 2021 and held it in 8 quarters.
Balyasny Asset Management's Bioventus position peaked at $1.18M in Q2 2023.
156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.